Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AFMD
1826
DELISTED
Affimed
AFMD
| $4.73M | 0.01% |
+255,731
| New | +$4.83M |
|
|
SRRA
1827
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $4.72M | 0.01% |
57,011
+26,465
| +87% | +$3M |
|
|
SF
1828
Stifel
SF
$12B
| $4.72M | 0.01% |
179,231
-2,482,418
| -93% | -$70.3M |
|
1829
Starbucks
SBUX
$121B
| $4.7M | 0.01% |
81,194
-296,652
| -79% | -$17.1M |
|
1830
iShares S&P 100 ETF
OEF
$20.3B
| $4.7M | 0.01% |
40,480
+3,213
| +9% | +$389K |
|
1831
Enphase Energy
ENPH
$4.94B
| $4.69M | 0.01% |
1,026,880
+812,493
| +379% | +$2.47M |
|
1832
Enova International
ENVA
$6.06B
| $4.67M | 0.01% |
+211,785
| New | +$4.26M |
|
1833
Carriage Services
CSV
$553M
| $4.66M | 0.01% |
168,576
+155,602
| +1,199% | +$4.21M |
|
1834
Yatra Online
YTRA
$65.9M
| $4.66M | 0.01% |
704,609
+477,328
| +210% | +$3.36M |
|
|
KYNB
1835
Kyntra Bio
KYNB
$32.8M
| $4.66M | 0.01% |
4,030
+3,336
| +481% | +$4.39M |
|
1836
PUT
Nike
NKE
$58.6B
| $4.65M | 0.01% |
70,000
-200,000
| -74% | -$13.2M |
|
|
SHYF
1837
DELISTED
The Shyft Group
SHYF
| $4.64M | 0.01% |
269,860
-128,473
| -32% | -$2M |
|
1838
Telus
TU
$15.5B
| $4.64M | 0.01% |
+263,722
| New | +$4.81M |
|
|
CZR
1839
DELISTED
Caesars Entertainment Corporation
CZR
| $4.64M | 0.01% |
412,078
-8,449,807
| -95% | -$108M |
|
1840
Harmony Gold Mining
HMY
$14.3B
| $4.63M | 0.01% |
1,939,017
-660,442
| -25% | -$1.32M |
|
1841
iShares TIPS Bond ETF
TIP
$15.1B
| $4.62M | 0.01% |
40,893
-30,317
| -43% | -$3.41M |
|
1842
Booz Allen Hamilton
BAH
$8.88B
| $4.61M | 0.01% |
119,083
-25,981
| -18% | -$1M |
|
|
ONDK
1843
DELISTED
On Deck Capital, Inc.
ONDK
| $4.61M | 0.01% |
824,670
-1,179,960
| -59% | -$6M |
|
1844
NatWest
NWG
$74.9B
| $4.6M | 0.01% |
577,008
+500,416
| +653% | +$4.21M |
|
|
ANH
1845
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $4.59M | 0.01% |
957,334
+914,516
| +2,136% | +$4.52M |
|
1846
Princeton Bancorp
BPRN
$288M
| $4.59M | 0.01% |
133,098
+49,330
| +59% | +$1.62M |
|
|
AAC
1847
DELISTED
AAC Holdings
AAC
| $4.59M | 0.01% |
399,477
+120,373
| +43% | +$1.18M |
|
1848
Precigen
PGEN
$2.61B
| $4.58M | 0.01% |
298,737
+200,193
| +203% | +$2.86M |
|
1849
CALL
Monster Beverage
MNST
$95.5B
| $4.58M | 0.01% |
+320,000
| New | +$5M |
|
1850
Intercontinental Exchange
ICE
$90.8B
| $4.57M | 0.01% |
63,036
-1,550,315
| -96% | -$113M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.